$Viridian Therapeutics (VRDN.US)$
Can Viridian's $717M Cash Runway and Promising TED Treatment Impress Biotech Investors?

$Viridian Therapeutics (VRDN.US)$
Will become the defacto drug for TED treatment and corner the market. Even helps to treat chronic TED. The results are truly impressive. The current market size for this disease treatment is about USD2bn

$Viridian Therapeutics (VRDN.US)$ WTF happens?!??

$Viridian Therapeutics (VRDN.US)$ bought pullback at 18.1
somehow lost on $NIO Inc (NIO.US)$ earlier but we can't stop won't stop 😂😭

$Viridian Therapeutics (VRDN.US)$ Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
2 MINUTES AGO, 4:01 PM EDT
VIA BUSINESSWIRE

$SMX (Security Matters) (SMX.US)$ $BIO-key International (BKYI.US)$ $Silexion Therapeutics (SLXN.US)$ $BloomZ (BLMZ.US)$ $Viridian Therapeutics (VRDN.US)$
📊⚡️📊

$Viridian Therapeutics (VRDN.US)$
Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease
Viridian Therapeutics (NASDAQ: VRDN) announced positive topline results from the THRIVE Phase 3 clinical trial of veligrotug (VRDN-001) in patients with active thyroid eye disease (TED). The trial met all primary and secondary endpoints, showing significant improvements in proptosis, diplopia, and clinic...

$Haleon (HLN.US)$ this is one dip I got to scoop up...its a no brainer. The largest OTC drug maker.
$Day One Biopharmaceuticals (DAWN.US)$ $Viridian Therapeutics (VRDN.US)$ $Bristol-Myers Squibb (BMY.US)$ $BioNTech (BNTX.US)$